Asia-Pacific Molecular Diagnostics Market
The Molecular Diagnostics Market is segmented on the basis of Product & Services, Technology, Application, End-user and Region. Based on Product & Services, the market is segmented into instruments, reagents & Kits, and software & services.
Asia-Pacific Molecular Diagnostics Market Overview
Molecular Diagnostics is used to identify or monitor biomarkers associated with any particular diseases or conditions. This test could also help in detecting and quantifying the presence of specific bacteria and viruses. These devices help surgeons in deciding that which therapy would work best on different patients. Molecular Diagnostics detect the diseases by analyzing RNA (Ribonucleic Acid) or DNA (Deoxyribonucleic Acid) in humans. These diagnostics are mainly used for clinical testing devices that are supplied in clinics, hospitals, laboratories, and research institutes.
Infectious diseases and Cancer is becoming threat for the Asian region specifically India. According to the statistics in 2016, approximately 5.1 million people are living with HIV in Asian region. In 2015, there were an estimated 300,000 new infections in the Asia- Pacific. In Addition, Institute of Medical Research stated the estimation of Cancer, “1.5 lakh breast cancer cases and 1 lakh cervix cancer, new cases were recorded in India”.
Personalized medicine is also becoming trend in medical industry. Food & Drug Administration (FDA) approval for the treatments with tailored medicines is gaining the attention of health professionals and health care manufacturing companies. China has involved in the launch of innovative devices which have techniques for multiple therapeutic areas. Meanwhile, Japan is also launching its new products in vitro diagnostics. Hence, Asia- Pacific is expected to capture largest share in the market owing to increase in infectious diseases and innovation of personalized medicines.
Asia-Pacific Molecular Diagnostics Market Segmentation
The Molecular Diagnostics Market is segmented on the basis of Product & Services, Technology, Application, End-user and Region. Based on Product & Services, the market is segmented into instruments, reagents & Kits, and software & services. Reagents & Kits is expected to gather largest share in the market due to rising demand of reagents in clinical centers and diagnostics centers. Based on Technology, market is segmented into Polymerase Chain Reaction (PCR), Microarray, Isothermal Nucleic Acid Amplification Technology (INAAT), Hybridization, Microarray, DNA Sequencing and Next-Generation Sequencing.
Based on Application, the market is segmented into six types such as Infectious diseases molecular testing, Molecular oncology testing, Inherited diseases molecular testing, Identity testing, Tissue type testing and Pharmacogenetics testing. Infectious Diseases includes Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG), Human Papillomavirus (HPV), Human Immunodeficiency Virus (HIV), Tuberculosis (TB), Hepatitis B, Hepatitis C, Tuberculosis (TB), Methicillin-Resistant Staphylococcus Aureus (MRSA) and other infectious diseases. On the other hand, oncology is further divided into Breast Cancer, Prostate Cancer, Colorectal Cancer and others. The infectious diseases molecular testing is mostly preferred in the hospitals and clinical centers. Based on End-User, the market is segmented into i clinics, hospitals, laboratories, and research institutes. Based on Country, market is segmented into China, India, Japan, Australia, India, South Korea, Singapore, and Rest of Asia-Pacific.
Asia-Pacific Molecular Diagnostics Market Key Companies
The report covers the analysis of key stake holders of the Molecular Diagnostics market. Key companies profiled in the report includeAbbott Laboratories,Qiagen N.V,Roche Diagnostics,Grifols,Siemens Healthcare (Siemens AG),Becton Dickinson and Company and Danaher Corporation.
Asia-Pacific Molecular Diagnostics Market Segmentation
Market Segmentation:
By Product & Services
- Reagents & Kits
- Instruments
- Software& Services
By Technology
- Polymerase Chain Reaction
- Isothermal Nucleic Acid Amplification Technology
- Hybridization
- DNA Sequencing & Next-Generation Sequencing
- Microarray
- Other Technologies
By Application
- Infectious Diseases
- Chlamydia Trachomatis & Neisseria Gonorrhoea
- Hepatitis B & Hepatitis C
- Human Papillomavirus
- Human Immunodeficiency Virus
- Tuberculosis
- Methicillin-Resistant Staphylococcus Aurous
- Others
- Oncology
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Other Cancers
- Blood Screening
- Genetic Tests
- Microbiology
- Other Applications
By End User
- Hospital & Academic Laboratories
- Reference Laboratories
- Other End Users
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Australia
- Rest of Asia-Pacific
Company Profiled
- Abbott Laboratories
- Qiagen N.V
- Roche Diagnostics
- Grifols
- Siemens Healthcare (Siemens AG)
- Becton Dickinson and Company
- Danaher Corporation
Unique Offerings from KBV Research
- Exhaustive coverage of Asia-PacificMolecular Diagnostics Market
- Highest number of market tables
- Unique “Market Research & Analytics Tool” to provide instant comparative analysis within the report
- Subscription based model available
- Free of cost quarterly updates
- Free of cost automatic pdf report generation
- Guaranteed best price
- Assured post sales research support with 10% customization free
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia-Pacific Molecular Diagnostics Market, by Product & Services
1.4.2 Asia-Pacific Molecular Diagnostics Market, by Technology
1.4.3 Asia-Pacific Molecular Diagnostics Market, by Application
1.4.4 Asia-Pacific Molecular Diagnostics Market, by End User
1.4.5 Asia-Pacific Molecular Diagnostics Market, by Country
1.5 Methodology for the research
Chapter 2. Executive Summary
Chapter 3. Market Overview
3.1 Introduction
3.2 Drivers, Restraints and Opportunities
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Asia-Pacific Molecular Diagnostics Market
4.1 Asia-Pacific Molecular Diagnostics Market by Product & Services
4.1.1 Asia-Pacific Molecular Diagnostics Reagents & Kits Market by Country
4.1.2 Asia-Pacific Molecular Diagnostics Instruments Market by Country
4.1.3 Asia-Pacific Molecular Diagnostics Software & Services Market by Country
Chapter 5. Asia-Pacific Molecular Diagnostics Market by Technology
5.1 Introduction
5.1.1 Asia-Pacific Polymerase Chain Reaction Molecular Diagnostics Market by Country
5.1.2 Asia-Pacific Isothermal Nucleic Acid Amplification Technology Molecular Diagnostics Market by Country
5.1.3 Asia-Pacific Hybridization Molecular Diagnostics Market by Country
5.1.4 Asia-Pacific DNA Sequencing & Next-Generation Sequencing Molecular Diagnostics Market by Country
5.1.5 Asia-Pacific Microarray Molecular Diagnostics Market by Country
5.1.6 Asia-Pacific Other Technologies Market by Country
Chapter 6. Asia-Pacific Molecular Diagnostics Market by Application
6.1 Introduction
6.1.1 Asia-Pacific Infectious Diseases Molecular Diagnostics Market by Country
6.1.2 Asia-Pacific Infectious Diseases Molecular Diagnostics Market by Type
6.1.2.1 Asia-Pacific Chlamydia Trachomatis & Neisseria Gonorrhea Molecular Diagnostics Market by Country
6.1.2.2 Asia-Pacific Hepatitis B & Hepatitis C Molecular Diagnostics Market by Country
6.1.2.3 Asia-Pacific Human Papillomavirus Molecular Diagnostics Market by Country
6.1.2.4 Asia-Pacific Human Immunodeficiency Virus Molecular Diagnostics Market by Country
6.1.2.5 Asia-Pacific Tuberculosis Molecular Diagnostics Market by Country
6.1.2.6 Asia-Pacific Methicillin-Resistant Staphylococcus Aurous Molecular Diagnostics Market by Country
6.1.2.7 Asia-Pacific Molecular Diagnostics in Other Infectious Diseases Market by Country
6.1.3 Asia-Pacific Oncology Molecular Diagnostics Market by Country
6.1.4 Asia-Pacific Oncology Molecular Diagnostics Market by Type
6.1.4.1 Asia-Pacific Breast Cancer Molecular Diagnostics Market by Country
6.1.4.2 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market by Country
6.1.4.3 Asia-Pacific Prostate Cancer Molecular Diagnostics Market by Country
6.1.4.4 Asia-Pacific Other Cancers Molecular Diagnostics Market by Country
6.1.5 Asia-Pacific Blood Screening Molecular Diagnostics Market by Country
6.1.6 Asia-Pacific Genetic Tests Molecular Diagnostics Market by Country
6.1.7 Asia-Pacific Microbiology Molecular Diagnostics Market by Country
6.1.8 Asia-Pacific Other Applications Market by Country
Chapter 7. Asia-Pacific Molecular Diagnostics Market by End User
7.1 Introduction
7.1.1 Asia-Pacific Molecular Diagnostics Market for Hospital & Academic Laboratories by Country
7.1.2 Asia-Pacific Molecular Diagnostics Market for Reference Laboratories by Country
7.1.3 Asia-Pacific Molecular Diagnostics Market for Other End Users by Country
Chapter 8. Asia-Pacific Molecular Diagnostics Market by Country
8.1 Introduction
8.2 China Molecular Diagnostics Market
8.2.1 China Molecular Diagnostics Market by Product & Services
8.2.2 China Molecular Diagnostics Market by Technology
8.2.3 China Molecular Diagnostics Market by Application
8.2.3.1 China Infectious Diseases Molecular Diagnostics Market by Type
8.2.3.2 China Oncology Molecular Diagnostics Market by Type
8.2.4 China Molecular Diagnostics Market by End User
8.3 Japan Molecular Diagnostics Market
8.3.1 Japan Molecular Diagnostics Market by Product & Services
8.3.2 Japan Molecular Diagnostics Market by Technology
8.3.3 Japan Molecular Diagnostics Market by Application
8.3.3.1 Japan Infectious Diseases Molecular Diagnostics Market by Type
8.3.3.2 Japan Oncology Molecular Diagnostics Market by Type
8.3.4 Japan Molecular Diagnostics Market by End User
8.4 India Molecular Diagnostics Market
8.4.1 India Molecular Diagnostics Market by Product & Services
8.4.2 India Molecular Diagnostics Market by Technology
8.4.3 India Molecular Diagnostics Market by Application
8.4.3.1 India Infectious Diseases Molecular Diagnostics Market by Type
8.4.3.2 India Oncology Molecular Diagnostics Market by Type
8.4.4 India Molecular Diagnostics Market by End User
8.5 South Korea Molecular Diagnostics Market
8.5.1 South Korea Molecular Diagnostics Market by Product & Services
8.5.2 South Korea Molecular Diagnostics Market by Technology
8.5.3 South Korea Molecular Diagnostics Market by Application
8.5.3.1 South Korea Infectious Diseases Molecular Diagnostics Market by Type
8.5.3.2 South Korea Oncology Molecular Diagnostics Market by Type
8.5.4 South Korea Molecular Diagnostics Market by End User
8.6 Australia Molecular Diagnostics Market
8.6.1 Australia Molecular Diagnostics Market by Product & Services
8.6.2 Australia Molecular Diagnostics Market by Technology
8.6.3 Australia Molecular Diagnostics Market by Application
8.6.3.1 Australia Infectious Diseases Molecular Diagnostics Market by Type
8.6.3.2 Australia Oncology Molecular Diagnostics Market by Type
8.6.4 Australia Molecular Diagnostics Market by End User
8.7 Singapore Molecular Diagnostics Market
8.7.1 Singapore Molecular Diagnostics Market by Product & Services
8.7.2 Singapore Molecular Diagnostics Market by Technology
8.7.3 Singapore Molecular Diagnostics Market by Application
8.7.3.1 Singapore Infectious Diseases Molecular Diagnostics Market by Type
8.7.3.2 Singapore Oncology Molecular Diagnostics Market by Type
8.7.4 Singapore Molecular Diagnostics Market by End User
8.8 Rest of Asia-Pacific Molecular Diagnostics Market
8.8.1 Rest of Asia-Pacific Molecular Diagnostics Market by Product & Services
8.8.2 Rest of Asia-Pacific Molecular Diagnostics Market by Technology
8.8.3 Rest of Asia-Pacific Molecular Diagnostics Market by Application
8.8.3.1 Rest of Asia-Pacific Infectious Diseases Molecular Diagnostics Market by Type
8.8.3.2 Rest of Asia-Pacific Oncology Molecular Diagnostics Market by Type
8.8.4 Rest of Asia-Pacific Molecular Diagnostics Market by End User
Chapter 9. Company Profiles
9.1 Abbott Laboratories
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.2 Qiagen N.V.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.3 Roche Diagnostics
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.4 Grifols
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.5 Siemens Healthcare (Siemens AG)
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.6 Becton Dickinson and Company
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.7 Danaher Corporation
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
LIST OF TABLES
TABLE 1 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION
TABLE 2 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION
TABLE 3 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION
TABLE 4 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION
TABLE 5 ASIA-PACIFIC MOLECULAR DIAGNOSTICS REAGENTS & KITS MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 6 ASIA-PACIFIC MOLECULAR DIAGNOSTICS REAGENTS & KITS MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 7 ASIA-PACIFIC MOLECULAR DIAGNOSTICS INSTRUMENTS MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 8 ASIA-PACIFIC MOLECULAR DIAGNOSTICS INSTRUMENTS MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 9 ASIA-PACIFIC MOLECULAR DIAGNOSTICS SOFTWARE & SERVICES MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 10 ASIA-PACIFIC MOLECULAR DIAGNOSTICS SOFTWARE & SERVICES MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 11 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION
TABLE 12 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION
TABLE 13 ASIA-PACIFIC POLYMERASE CHAIN REACTION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 14 ASIA-PACIFIC POLYMERASE CHAIN REACTION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 15 ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 16 ASIA-PACIFIC ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 17 ASIA-PACIFIC HYBRIDIZATION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 18 ASIA-PACIFIC HYBRIDIZATION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 19 ASIA-PACIFIC DNA SEQUENCING & NEXT-GENERATION SEQUENCING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 20 ASIA-PACIFIC DNA SEQUENCING & NEXT-GENERATION SEQUENCING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 21 ASIA-PACIFIC MICROARRAY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 22 ASIA-PACIFIC MICROARRAY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 23 ASIA-PACIFIC OTHER TECHNOLOGIES MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 24 ASIA-PACIFIC OTHER TECHNOLOGIES MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 25 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION
TABLE 26 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION
TABLE 27 ASIA-PACIFIC INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 28 ASIA-PACIFIC INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 29 ASIA-PACIFIC INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION
TABLE 30 ASIA-PACIFIC INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION
TABLE 31 ASIA-PACIFIC CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHEA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 32 ASIA-PACIFIC CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHEA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 33 ASIA-PACIFIC HEPATITIS B & HEPATITIS C MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 34 ASIA-PACIFIC HEPATITIS B & HEPATITIS C MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 35 ASIA-PACIFIC HUMAN PAPILLOMAVIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 36 ASIA-PACIFIC HUMAN PAPILLOMAVIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 37 ASIA-PACIFIC HUMAN IMMUNODEFICIENCY VIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 38 ASIA-PACIFIC HUMAN IMMUNODEFICIENCY VIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 39 ASIA-PACIFIC TUBERCULOSIS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 40 ASIA-PACIFIC TUBERCULOSIS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 41 ASIA-PACIFIC METHICILLIN-RESISTANT STAPHYLOCOCCUS AUROUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 42 ASIA-PACIFIC METHICILLIN-RESISTANT STAPHYLOCOCCUS AUROUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 43 ASIA-PACIFIC MOLECULAR DIAGNOSTICS IN OTHER INFECTIOUS DISEASES MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 44 ASIA-PACIFIC MOLECULAR DIAGNOSTICS IN OTHER INFECTIOUS DISEASES MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 45 ASIA-PACIFIC ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 46 ASIA-PACIFIC ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 47 ASIA-PACIFIC ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION
TABLE 48 ASIA-PACIFIC ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION
TABLE 49 ASIA-PACIFIC BREAST CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 50 ASIA-PACIFIC BREAST CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 51 ASIA-PACIFIC COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 52 ASIA-PACIFIC COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 53 ASIA-PACIFIC PROSTATE CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 54 ASIA-PACIFIC PROSTATE CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 55 ASIA-PACIFIC OTHER CANCERS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 56 ASIA-PACIFIC OTHER CANCERS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 57 ASIA-PACIFIC BLOOD SCREENING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 58 ASIA-PACIFIC BLOOD SCREENING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 59 ASIA-PACIFIC GENETIC TESTS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 60 ASIA-PACIFIC GENETIC TESTS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 61 ASIA-PACIFIC MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 62 ASIA-PACIFIC MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 63 ASIA-PACIFIC OTHER APPLICATIONS MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 64 ASIA-PACIFIC OTHER APPLICATIONS MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 65 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION
TABLE 66 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION
TABLE 67 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 68 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 69 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 70 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 71 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 72 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 73 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION
TABLE 74 ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION
TABLE 75 CHINA MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION
TABLE 76 CHINA MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION
TABLE 77 CHINA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION
TABLE 78 CHINA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION
TABLE 79 CHINA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION
TABLE 80 CHINA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION
TABLE 81 CHINA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION
TABLE 82 CHINA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION
TABLE 83 CHINA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION
TABLE 84 CHINA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION
TABLE 85 CHINA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION
TABLE 86 CHINA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION
TABLE 87 CHINA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION
TABLE 88 CHINA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION
TABLE 89 JAPAN MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION
TABLE 90 JAPAN MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION
TABLE 91 JAPAN MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION
TABLE 92 JAPAN MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION
TABLE 93 JAPAN MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION
TABLE 94 JAPAN MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION
TABLE 95 JAPAN MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION
TABLE 96 JAPAN MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION
TABLE 97 JAPAN INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION
TABLE 98 JAPAN INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION
TABLE 99 JAPAN ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION
TABLE 100 JAPAN ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION
TABLE 101 JAPAN MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION
TABLE 102 JAPAN MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION
TABLE 103 INDIA MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION
TABLE 104 INDIA MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION
TABLE 105 INDIA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION
TABLE 106 INDIA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION
TABLE 107 INDIA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION
TABLE 108 INDIA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION
TABLE 109 INDIA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION
TABLE 110 INDIA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION
TABLE 111 INDIA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION
TABLE 112 INDIA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION
TABLE 113 INDIA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION
TABLE 114 INDIA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION
TABLE 115 INDIA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION
TABLE 116 INDIA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION
TABLE 117 SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION
TABLE 118 SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION
TABLE 119 SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION
TABLE 120 SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION
TABLE 121 SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION
TABLE 122 SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION
TABLE 123 SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION
TABLE 124 SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION
TABLE 125 SOUTH KOREA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION
TABLE 126 SOUTH KOREA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION
TABLE 127 SOUTH KOREA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION
TABLE 128 SOUTH KOREA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION
TABLE 129 SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION
TABLE 130 SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION
TABLE 131 AUSTRALIA MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION
TABLE 132 AUSTRALIA MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION
TABLE 133 AUSTRALIA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION
TABLE 134 AUSTRALIA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION
TABLE 135 AUSTRALIA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION
TABLE 136 AUSTRALIA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION
TABLE 137 AUSTRALIA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION
TABLE 138 AUSTRALIA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION
TABLE 139 AUSTRALIA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION
TABLE 140 AUSTRALIA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION
TABLE 141 AUSTRALIA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION
TABLE 142 AUSTRALIA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION
TABLE 143 AUSTRALIA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION
TABLE 144 AUSTRALIA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION
TABLE 145 SINGAPORE MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION
TABLE 146 SINGAPORE MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION
TABLE 147 SINGAPORE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION
TABLE 148 SINGAPORE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION
TABLE 149 SINGAPORE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION
TABLE 150 SINGAPORE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION
TABLE 151 SINGAPORE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION
TABLE 152 SINGAPORE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION
TABLE 153 SINGAPORE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION
TABLE 154 SINGAPORE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION
TABLE 155 SINGAPORE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION
TABLE 156 SINGAPORE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION
TABLE 157 SINGAPORE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION
TABLE 158 SINGAPORE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION
TABLE 159 REST OF ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION
TABLE 160 REST OF ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION
TABLE 161 REST OF ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION
TABLE 162 REST OF ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION
TABLE 163 REST OF ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION
TABLE 164 REST OF ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION
TABLE 165 REST OF ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION
TABLE 166 REST OF ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION
TABLE 167 REST OF ASIA-PACIFIC INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION
TABLE 168 REST OF ASIA-PACIFIC INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION
TABLE 169 REST OF ASIA-PACIFIC ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION
TABLE 170 REST OF ASIA-PACIFIC ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION
TABLE 171 REST OF ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION
TABLE 172 REST OF ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION
TABLE 173 KEY INFORMATION – ABBOTT LABORATORIES.
TABLE 174 KEY INFORMATION – QUIAGEN N.V.
TABLE 175 KEY INFORMATION – ROCHE DIAGNOSTIC
TABLE 176 KEY INFORMATION – GRIFOLS
TABLE 177 KEY INFORMATION – SIEMENS HEALTHCARE (SIEMENS AG)
TABLE 178 KEY INFORMATION – BECTON DICKINSON AND COMPANY
TABLE 179 KEY INFORMATION – DANAHER CORPORATION
